ESPR | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ESPR

An SI Board Since August 2000

Posts	SubjectMarks	Bans	Symbol
16	8	0	ESPR

Emcee: StockDoc	Type: Unmoderated

Introduction Market Data Compact

This unique new biotech company has an original and promising approach to prevent or cure cardiovascular and cerebrovascular disease. These diseases directly account for 2/3 of all human deaths and thus are far more important than cancer and all other diseases combined. ESPR's approach, in certain ways, resemble those of other biotech companies that target angiogenesis as a method to cure cancer. Let's hope they all succeed.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
16	Pfizer to buy ESPR for $35 per share. story.news.yahoo.com <b>Pfizer to	Glenn Petersen	-	12/21/2003
15	Durus Bails Out of Various Medical Holdings By Robert Steyer Staff Reporter 10	keokalani'nui	-	10/1/2003
14	FWIW, local, largely derivative, coverage in the Ann Arbor News: <i>Arter	RCMac	-	6/27/2003
13	Research report from April 2002 on ESPR, fairly detailed, available for free (th	RCMac	-	6/26/2003
12	Forbes: <i>A Big Win For Esperion </i> Matthew Herper, 06.26.03, 1:	RCMac	-	6/26/2003
11	ESPR reports initial results from Phase 2 of ETC-216 for <i>regression<	RCMac	-	6/26/2003
10	Whatever track I was on here I lost long ago. Gotta finish the Rs before tiltin	keokalani'nui	-	5/13/2002
9	And an update from one of the main competitors: >>Atherosclerosis 2001 Ju	tuck	-	5/13/2002
8	Still follow this one, Wilder? Just found it, myself, and decided to update Jas	tuck	-	5/13/2002
7	Abstracts from a PubMed search on "Apo A-I Milano" Jason <i> B	tnsaf	-	7/15/2001
6	Robertson-Stephens starts coverage of ESPR: robertsonstephens.com Esperion Ther	RCMac	-	6/21/2001
5	Press Release SOURCE: Esperion Therapeutics, Inc. Esperion Therapeutics Announce	keokalani'nui	-	5/2/2001
4	Wednesday May 2, 1:26 am Eastern Time Press Release SOURCE: Global News Network	keokalani'nui	-	5/2/2001
3	Too much junk on ESPR on Yahoo. SI, however, is almost dead. Maybe nothing to di	StockDoc	-	11/11/2000
2	Lots of discussion on Yahoo and Raging Bull Boards Doc! Uncle Rumple	Stiltskin	-	11/10/2000
1	Esperion does not seem to get any attention here. Where are you folks? Sleeping?	StockDoc	-	10/24/2000

Go to reply# or date (mm/dd/yy):